Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes

被引：0
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, 1 1 5 Sendagi Bunkyo Ku, Tokyo 1138602, Japan
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2023年 / 37卷 / 04期
关键词：
OUTCOMES;
D O I：
10.1007/s10557-022-07374-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 620
页数：2
相关论文
共 50 条
  • [1] Cardiovascular Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Type 2 Diabetes
    Woo, Vincent C.
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 61 - 67
  • [2] The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors
    Tanna, Monique S.
    Goldberg, Lee R.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (06) : 764 - 768
  • [3] Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes
    Suissa, Karine
    Schneeweiss, Sebastian
    Douros, Antonios
    Yin, Hui
    Patorno, Elisabetta
    Azoulay, Laurent
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [4] Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer
    Zhang, Allan
    Kalil, Ramsey
    Marzec, Alexander
    Coulter, Stephanie A.
    Virani, Salim
    Patel, Kershaw V.
    Segar, Matthew W.
    TEXAS HEART INSTITUTE JOURNAL, 2024, 51 (01)
  • [5] Perioperative Considerations for the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes
    Peacock, Sharon C.
    Lovshin, Julie A.
    Cherney, David Z. I.
    ANESTHESIA AND ANALGESIA, 2018, 126 (02) : 699 - 704
  • [6] Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis
    Savarese, Gianluigi
    D'Amore, Carmen
    Federici, Massimo
    De Martino, Fabiana
    Dellegrottaglie, Santo
    Marciano, Caterina
    Ferrazzano, Francesca
    Losco, Teresa
    Lund, Lars H.
    Trimarco, Bruno
    Rosano, Giuseppe M. C.
    Perrone-Filardi, Pasquale
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 595 - 601
  • [7] Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events
    Nelson, Adam J.
    Harrington, Josephine L.
    Kolkailah, Ahmed A.
    Pagidipati, Neha J.
    McGuire, Darren K.
    HEART FAILURE CLINICS, 2022, 18 (04) : 597 - 607
  • [8] Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes
    Lam, Steven Ho Man
    Alam, Uazman
    Lip, Gregory Yoke Hong
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 223 : 183 - 185
  • [9] Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer
    Chiang, Cho-Han
    Chiang, Cho-Hung
    Chiang, Cho-Hsien
    Ma, Kevin Sheng-Kai
    Peng, Chun-Yu
    Hsia, Yuan Ping
    Horng, Chuan-Sheng
    Chen, Cheng-Ying
    Chang, Yu-Cheng
    See, Xin Ya
    Chen, Yuan-Jen
    Wang, Shih-Syuan
    Suero-Abreu, Giselle A.
    Peterson, L. R.
    Thavendiranathan, Paaladinesh
    Armand, Philippe
    Peng, Cheng-Ming
    Shiah, Her-Shyong
    Neilan, Tomas G.
    HEART, 2023, 109 (06) : 470 - 477
  • [10] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention
    Reid, Jessica
    Rana, Khyatiben
    Niman, Stephanie
    Sheikh-Ali, Mae
    Lewis, Todd
    Choksi, Rushab R.
    Goldfaden, Rebecca F.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 419 - 429
12345